MJH Associates has acquired UBM Life Sciences’ healthcare media assets from Informa
MJH Associates‚ Inc. (MJH) has acquired major market media assets from the UBM Life Sciences Group of Informa PLC (INF.L). The transaction consideration was in excess of US$100 million.
MJH is the largest privately held, independent full-service medical media company in the US dedicated to delivering trusted healthcare news across multiple channels. Over 600 MJH associates are dedicated to providing healthcare professionals with the information and resources they need to optimize patient outcomes. MJH combines the reach and influence of its powerful portfolio of digital and print product lines, live events, educational programs and market research with the customization capabilities of a boutique firm. Clients include world-leading pharmaceutical, medical device, diagnostic and biotech companies.
The acquisition of UBM Life Sciences Group assets includes iconic multimedia platforms in the healthcare, animal care, pharma sciences and dental fields as well as three preeminent veterinarian conferences.
Informa is a leading international exhibitions, events, information services and scholarly research group with annual revenues approaching US$4 billion. It helps commercial, professional and academic communities work smarter and make better decisions faster, through specialist content and intelligence, and provide opportunities to connect and learn.
One of Oaklins’ TMT specialist teams in New York acted as the exclusive M&A advisor to MJH Associates in this transaction.
Michael J. Hennessy Jr.
President, MJH Associates, Inc.
Sprechen Sie mit dem Deal Team
Roland DeSilva
Oaklins DeSilva+Phillips
Jack Noble
Oaklins DeSilva+Phillips
Transaktionen
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Mehr erfahrenGroupe JVS has acquired Abelium Collectivités
Groupe JVS has acquired Abelium Collectivités, which was subsequently rebranded as Familea. The transaction, supported by CAPZA as a minority shareholder and Bpifrance, strengthens Groupe JVS’s strategy in the childcare and family services sector while expanding its offering to local public sector stakeholders.
Mehr erfahrenMiddlecon has been acquired by Nion
Middlecon has been acquired by Nion, a digital consultancy backed by Stella Capital. The acquisition strengthens Nion’s capabilities in data management and advanced analytics, enabling it to undertake larger and more complex data-driven initiatives for its customers. The partnership with Nion provides Middlecon with a strong foundation for continued growth and expansion.
Mehr erfahren